article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

But what happens when that in-person meeting is no longer a viable option for your prospect? Bearing the brunt of these COVID19 restrictions, pharmaceutical reps have had a hard time getting in the door to make sales, and their employers have noticed: Limited In-Person Access To HCPs. Fewer Networking & Industry Trade Show Events.

Pharma 52
article thumbnail

Dawn of a new indication: how to study drugs for aging 

Pharmaceutical Technology

The UK also faces similar regulatory challenges as some public health officials and drug regulators are slow to collaborate with pharmaceutical researchers on aging-related work. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

FDA 145